Evidence map›Paper›PMID 38068397›Full record

ArticleJournal of clinical medicine2023

Expired Platelet Concentrate Up-Cycling: Growth Factor-Rich Bioproduct Preparation for FBS Substitute.

Eun Hye Lee, So Young Chun, Bo Hyun Yoon, Minji Jeon, Yun-Sok Ha, Jae-Wook Chung, Joonbeom Kwon, Jeongshik Kim, Dae Hwan Kim, Sang-Joon Park and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Eun Hye LeeJoint Institute of Regenerative Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
So Young ChunBioMedical Research Institute, Kyungpook National University Hospital, Daegu 41940, Republic of Korea.
Bo Hyun YoonBioMedical Research Institute, Kyungpook National University Hospital, Daegu 41940, Republic of Korea.
Minji JeonJoint Institute of Regenerative Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
Yun-Sok HaDepartment of Urology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0003-3732-9814
Jae-Wook ChungDepartment of Urology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-1055-2357
Joonbeom KwonDepartment of Urology, Daegu Fatima Hospital, Daegu 41199, Republic of Korea.
Jeongshik KimDepartment of Pathology, Ulsan Joongang Hospital, Ulsan 44667, Republic of Korea.
Dae Hwan KimDepartment of Laboratory Animal Research Support Team, Yeungnam University, Daegu 42415, Republic of Korea.
Sang-Joon ParkDepartment of Histology, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.ORCID 0000-0003-4275-6060
Tae Gyun KwonDepartment of Urology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Bum Soo KimDepartment of Urology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-4873-3049
Hyun Tae KimDepartment of Urology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-4730-3776
Kyungpook National University · KRKyungpook National University Hospital · KRDaegu Fatima Hospital · KRYeungnam University · KR

Funding

Kyungpook National University Hospital 2021
6 · The paper itself

Abstract

Due to the short storage period, large quantities of platelet concentrate (PC) are expiring. The expired PC cannot be injected into a blood vessel, but the activity of bioactive molecules, especially growth factors, is still preserved. In this paper, we organized a process to obtain a growth factor-rich bioproduct for use as a supplement in human cell culture by optimizing freezing, thawing, and sterilization conditions. Each unit of PC displayed visual differences, diverse biochemical values, and growth factor concentrations. To minimize lot-to-lot variation, we pooled a minimum of 10 PC units. The concentrations of growth factors were maximized through five freeze-thaw cycles for 12 h at -80 °C for freezing and for 5 min at 36 °C for thawing. We used a cell strainer with 40 µm pores, followed by a 0.45 μm filter and a 0.22 μm filter sequentially to sterilize the bioproduct with minimizing loss. The obtained growth factors remained stable for 4-6 h at room temperature (23 °C), 24 h at 4 °C, and 12 months at -80 °C. Cellular responses to the growth factor-rich bioproduct were tested with primary human renal proximal tubule epithelial cells. The cells exhibited a significantly increased growth rate, compared to the fetal bovine serum (FBS)-treated control group. The cells maintained their characteristic cuboidal shape, and stem cells and renal progenitor cells also preserved their genetic characteristics during culture. Therefore, the growth factor-rich bioproduct isolated from expired PC through our process can be used as a medium supplement to replace FBS in human cell culture for clinical application.

Indexed as

expired platelet concentrate (PC)fetal bovine serum (FBS)growth factorshuman stem cell culturemedium supplement

Identifiers

PMID38068397
PMCPMC10707290
OpenAlexW4389047499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.